91 related articles for article (PubMed ID: 10892068)
1. [Can the symptoms of stroke be limited?].
Lindsberg PJ; Kaste M
Duodecim; 1997; 113(18):1765-70. PubMed ID: 10892068
[No Abstract] [Full Text] [Related]
2. Neuroprotection in acute ischemic stroke: are we there yet?
Shuaib A
Int J Stroke; 2006 May; 1(2):100-1. PubMed ID: 18706053
[No Abstract] [Full Text] [Related]
3. Life after SAINT.
Hallevi H; Aronowski J
Int J Stroke; 2007 Nov; 2(4):241-2. PubMed ID: 18705923
[No Abstract] [Full Text] [Related]
4. [Prospects of thrombolytic therapy for acute ischemic stroke].
Nakashima T; Minematsu K
Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
[TBL] [Abstract][Full Text] [Related]
5. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice.
Hoffman JR
Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529
[No Abstract] [Full Text] [Related]
6. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator approved for stroke.
Barber A; Gommans J
N Z Med J; 2005 May; 118(1214):U1432. PubMed ID: 15886728
[No Abstract] [Full Text] [Related]
8. [Thrombolytic therapy in stroke approved with reservation. Underlying evidence, practical guidelines and safety follow up].
Wahlgren NG
Lakartidningen; 2004 Feb; 101(8):674-7. PubMed ID: 15024940
[No Abstract] [Full Text] [Related]
9. Novel therapies for acute ischemic stroke.
Leker RR; Eichel R; Rafaeli G; Ben-Hur T
Isr Med Assoc J; 2006 Nov; 8(11):788-92. PubMed ID: 17180832
[TBL] [Abstract][Full Text] [Related]
10. Post stroke intervention: is the window widening?
Zhan X; Kuczynski B; Sharp FR
Neuropharmacology; 2011 May; 60(6):1000-2. PubMed ID: 21315742
[No Abstract] [Full Text] [Related]
11. Thrombolytic therapy for acute ischemic stroke: risks vs benefits.
Lindbloom EJ
J Fam Pract; 2003 Oct; 52(10):757, 761. PubMed ID: 14529595
[No Abstract] [Full Text] [Related]
12. [Guidelines for intravenous thrombolytic therapy in acute ischemic stroke with special reference to those by the Ad Hoc Committee of the Japan Stroke Society].
Minematsu K
No To Shinkei; 2006 Nov; 58(11):915-21. PubMed ID: 17133996
[No Abstract] [Full Text] [Related]
13. EMS mythology. EMS myth #2. Thombolytic therapy is the standard of care for acute ischemic stroke.
Bledsoe BE
Emerg Med Serv; 2003 Apr; 32(4):63-5. PubMed ID: 12705219
[No Abstract] [Full Text] [Related]
14. Stroke.
Choi D
Neurobiol Dis; 2000 Oct; 7(5):552-8. PubMed ID: 11042076
[No Abstract] [Full Text] [Related]
15. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided.
Boode B; Welzen V; Franke C; van Oostenbrugge R
Cerebrovasc Dis; 2007; 23(4):294-8. PubMed ID: 17199087
[TBL] [Abstract][Full Text] [Related]
16. Future of neuroprotective drugs in doubt.
Birmingham K
Nat Med; 2002 Jan; 8(1):5. PubMed ID: 11786882
[No Abstract] [Full Text] [Related]
17. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
18. Treating acute ischemic stroke.
Fisher M; Bastan B
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):626-32. PubMed ID: 18729014
[TBL] [Abstract][Full Text] [Related]
19. The SITS-MOST registry.
Toni D; Lorenzano S; Puca E; Prencipe M
Neurol Sci; 2006 Jun; 27 Suppl 3():S260-2. PubMed ID: 16752063
[TBL] [Abstract][Full Text] [Related]
20. NXY-059: a hopeful sign in the treatment of stroke.
Hess DC
Stroke; 2006 Oct; 37(10):2649-50. PubMed ID: 16946156
[No Abstract] [Full Text] [Related]
[Next] [New Search]
